Ingalls & Snyder LLC’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Sell
9,413
-10,218
-52% -$178K 0.01% 431
2025
Q4
$231K Sell
19,631
-1,884
-9% -$24.2K 0.01% 423
2025
Q3
$341K Buy
21,515
+500
+2% +$7.25K 0.01% 355
2025
Q2
$241K Buy
+21,015
New +$237K 0.01% 400
2015
Q4
Sell
-10,364
Closed -$67K 379
2015
Q3
$67K Buy
+10,364
New +$108K ﹤0.01% 347

Other funds holding CC

Ingalls & Snyder LLC's CC Position: Q1 2026 in Review

Ingalls & Snyder LLC reduced its Chemours (CC) stake by 52% in Q1 2026, selling an estimated $178K and leaving 9,413 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #431.

Ingalls & Snyder LLC first reported a position in CC in Q3 2015 and has held it in 5 quarters since. The position peaked at $341K in Q3 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Ingalls & Snyder LLC held 9,413 shares of Chemours worth $207K as of Q1 2026.
  • Ingalls & Snyder LLC sold 10,218 Chemours shares in Q1 2026, an estimated $178K.
  • Chemours made up 0.01% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #431 holding.
  • Ingalls & Snyder LLC first reported a position in Chemours in Q3 2015 and has held it in 5 quarters since.
  • Ingalls & Snyder LLC's Chemours position peaked at $341K in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.